logo

For the Inventor, By the Inventor

Canby, OR, United States of America

Omnigen Research, LLC


USPTO Granted Patents = 15

% Expired Patents = 26.7



Trademarks = 2

Forward Citations = 58

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Neil Elliott Forsberg (13 out of 14 patents)

silverMedal Steven Bruce Puntenney (13 out of 14 patents)

bronzeMedal Kenneth W Bafundo (2 out of 5 patents)

4.  A Bruce Johnson (2 out of 5 patents)

5.  David Calabotta (2 out of 7 patents)

6.  James D Chapman (2 out of 2 patents)

7.  Laun Hall (2 out of 2 patents)

8.  Robert Collier (2 out of 4 patents)

9.  Ra'anan Ariav (1 out of 1 patent)

10.  Timothy E Costigan (1 patent)

11.  Derek J McLean (0 patent)

12.  Elvin D Walker (0 patent)

13.  Erich M Jacobsen (0 patent)

14.  Taylor D Beairsto (0 patent)

15.  Gordon R Mitchell (0 patent)


15 patents:

1. 12458043 - Bacillus combination for administration to animals (2025-11-04),
2. 11653674 - combination for administration to animals (2023-05-23),
3. 11627749 - Composition and/or combination for aquaculture (2023-04-18),
4. 11419888 - Composition and method for promoting reduction of heat stress in animals (2022-08-23),
5. 10555964 - Composition and method for promoting reduction of heat stress in animals (2020-02-11),
6. 9173926 - Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function (2015-11-03),
7. 9114129 - Augmentation of titer for vaccination in animals (2015-08-25),
8. 8834868 - Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function (2014-09-16),
9. 8828402 - Augmentation of titer for vaccination in animals (2014-09-09),
10. 8663644 - Augmentation of titer for vaccination in animals (2014-03-04),
11. 8568715 - Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function (2013-10-29),
12. 8431133 - Augmentation of titer for vaccination in animals (2013-04-30),
13. 8236303 - Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function (2012-08-07),
14. 8142798 - Augmentation of titer for vaccination in animals (2012-03-27),
15. 7939066 - [object Object] (2011-05-10),
Omnigen Research, LLC, based in Canby, Oregon, specializes in advanced research and development in the field of biotechnology. The company focuses on creating innovative solutions that enhance genetic analysis and molecular diagnostics. With a commitment to improving health outcomes, Omnigen leverages cutting-edge technology to support research initiatives across various sectors, including healthcare and agriculture. Their expertise in genomic data analysis positions them as a key player in the evolving landscape of personalized medicine and biotechnology.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

15 Patents

#3 in Canby, OR

#210 in Oregon

#21,026 in US

#39,846 in the World

Canby, OR (US)
Canby, OR, United States of America

Omnigen Research, LLC

Forward Citations = 58

9 inventors:

goldMedal Neil Elliott Forsberg (13 out of 14 patents)

silverMedal Steven Bruce Puntenney (13 out of 14 patents)

bronzeMedal Kenneth W Bafundo (2 out of 5 patents)

4.  A Bruce Johnson (2 out of 5 patents)

5.  David Calabotta (2 out of 7 patents)

Please report any incorrect information to [email protected]
Loading…